Fundraising FoxSolstice Biologics
San Francisco, US · Founded 2012 · Delaware LLC · 1 employees on LinkedIn · 1 known investors
Find your way into Solstice Biologics
Sign up to see every warm intro you have to Solstice Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solstice Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
FM
Frank MuhlenbeckMr. Muhlenbeck is a Manager of the Issuer.
JB
John BorgesonMr. Borgeson is the Assistant Secretary of the Issuer.
LT
Louis TartagliaMr. Tartaglia is a Manager of the Issuer.
Board
RA
CG
SD
Steven DowdyBoard director
GR
George RehmMr. Rehm is a member of the Board of Managers of the Issuer.
Investors · 1
Reported raises · per SEC filings
Form D private placements$11.5M disclosed across 2 rounds · 2014–2015
▶$4MraisedDec 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$4MraisedDec 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John BorgesonExecutive Officer
- Robert AdelmanDirector
- Corey GoodmanExecutive Officer, Director, Promoter
- Curt BradshawExecutive Officer, Director, Promoter
- Steven DowdyDirector
- George RehmDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Dec 2015
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
▶$7.5MraisedOct 2014 · 2 investors · PharmaceuticalsRule 506(b)
▶$7.5MraisedOct 2014 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frank MuhlenbeckDirector
- Robert AdelmanDirector
- Steven DowdyDirector
- Curt BradshawDirector
- John BorgesonExecutive Officer
- Corey GoodmanExecutive Officer, Director
- Louis TartagliaDirector
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Sep 2014
- Incorporated
- Limited Liability Company, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Solstice Biologics went on to found or lead other companies.
Frequently asked questions
- Who are Solstice Biologics's investors?
- Solstice Biologics's investors include venBio Partners.
- How much funding has Solstice Biologics raised?
- Solstice Biologics has disclosed $11.5M raised across 2 rounds.
- Where is Solstice Biologics headquartered?
- Solstice Biologics is headquartered in San Francisco, US.